NASDAQ:ATOS

Atossa Genetics Stock Predictions

Healthcare > Biotechnology

Buy ATOS

*Your capital is at risk

$4.70

-0.150 (-3.09%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ATOS Prediction Chart

ATOS Predictions History

Latest community submissions for ATOS.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Dec 10, 2020	$1.00 -92.42%	$0.88	X	86.79%	1
Chuck.Gaetano.106120	May 23, 2019	$4.25 -89.14%	$2.61	X	37.16%	0
NameNotImportant Pro	May 6, 2019	$3.25 -92.70%	$2.97	X	90.57%	0
NameNotImportant Pro	May 3, 2019	$2.95 -93.44%	$3.00	X	98.33%	0
NameNotImportant Pro	Apr 29, 2019	$2.73 -93.83%	$2.95	V	92.54%	0
PumpTheseNumbers Pro	Apr 25, 2019	$3.80 -92.08%	$3.20	X	81.25%	0
JS Pro	Apr 25, 2019	$3.36 -93.00%	$3.20	V	95.00%	0
Ph.E1.BA.A1m.Huong.108750	Apr 24, 2019	$7.93 -84.81%	$3.48	X	0.00%	0
PumpTheseNumbers Pro	Apr 9, 2019	$2.70 -94.14%	$3.07	V	87.95%	0
JS Pro	Apr 9, 2019	$3.21 -93.03%	$3.07	X	95.44%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ATOS with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ATOSSA GENETICS INC.

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by